Amany M. Belal

Ta'if, Saudi Arabia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

Ufasomal Nanocarriers for Enhanced Cardiac Delivery of Nifedipine: A Novel Strategy to Mitigate Doxorubicin-Induced Cardiotoxicity in Breast Cancer Therapy.

Ufasomal Nanocarriers for Enhanced Cardiac Delivery of Nifedipine: A Novel Strategy to Mitigate Doxorubicin-Induced Cardiotoxicity in Breast Cancer Therapy.

Journal: Journal of drug targeting

Published: September 05, 2026

Management of coronary artery disease via simvastatin-loaded novasomes.

Management of coronary artery disease via simvastatin-loaded novasomes.

Journal: Journal of microencapsulation

Published: June 24, 2026

Control of breast cancer via anastrozole-loaded transbilosomes.

Control of breast cancer via anastrozole-loaded transbilosomes.

Journal: Journal of liposome research

Published: May 04, 2026

Management of diabetes mellitus-associated atherosclerosis via simvastatin-loaded novasomes.

Management of diabetes mellitus-associated atherosclerosis via simvastatin-loaded novasomes.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 08, 2026

Control of cardiotoxicity via nasal in-situ pH-sensitive transbilosomal formulation of candesartan.

Control of cardiotoxicity via nasal in-situ pH-sensitive transbilosomal formulation of candesartan.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 04, 2026

Enhancing the Efficacy and Bioavailability of Isoxsuprine for the Treatment of Cardiotoxicity: In vitro and In vivo Studies.

Enhancing the Efficacy and Bioavailability of Isoxsuprine for the Treatment of Cardiotoxicity: In vitro and In vivo Studies.

Journal: Journal of drug targeting

Published: March 16, 2026

Design and optimization of isoxsuprine-loaded novasomes for the attenuation of coronary artery disease in rats.

Design and optimization of isoxsuprine-loaded novasomes for the attenuation of coronary artery disease in rats.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: March 16, 2026

Enhancing the efficacy and bioavailability of isoxsuprine for the treatment of cardiotoxicity: in vitro and in vivo studies.

Enhancing the efficacy and bioavailability of isoxsuprine for the treatment of cardiotoxicity: in vitro and in vivo studies.

Journal: Journal of drug targeting

Published: March 16, 2026

Design, optimization, and in vivo assessment of in situ pH-sensitive quercetin transbilosomes for the treatment of diabetes mellitus-associated heart failure.

Design, optimization, and in vivo assessment of in situ pH-sensitive quercetin transbilosomes for the treatment of diabetes mellitus-associated heart failure.

Journal: Journal of drug targeting

Published: January 24, 2026

Therapeutic intervention with sinomenine and irisin to preserve cardiac function after ischaemia-reperfusion injury.

Therapeutic intervention with sinomenine and irisin to preserve cardiac function after ischaemia-reperfusion injury.

Journal: Experimental physiology

Published: December 11, 2025

Mitigating doxorubicin-induced toxicity in breast cancer treatment with in situ pH-sensitive carvedilol-loaded transbilosomes: in vitro and in vivo characterization.

Mitigating doxorubicin-induced toxicity in breast cancer treatment with in situ pH-sensitive carvedilol-loaded transbilosomes: in vitro and in vivo characterization.

Journal: Journal of drug targeting

Published: December 08, 2025

In vitro and in vivo evaluation of the therapeutic efficacy of in-situ pH-sensitive carvedilol-loaded novasomes as a therapy for diabetes-associated coronary artery disease.

In vitro and in vivo evaluation of the therapeutic efficacy of in-situ pH-sensitive carvedilol-loaded novasomes as a therapy for diabetes-associated coronary artery disease.

Journal: Journal of drug targeting

Published: October 30, 2025

Showing 1-12 of 101

Last Updated: 09/26/2026